Neutrogena Breaks Silence After Backlash Over Hayden Panettiere’s Death

The death of actress Hayden Panettiere has renewed public scrutiny of her long relationship with skincare company Neutrogena, with the brand now responding to criticism over how it handled the actress’s struggles with postpartum depression.

Panettiere, known for roles in television and film, died on Aug. 16 at the age of 36 after suffering cardiac arrest. According to reports cited by NTD Television, authorities were considering a possible overdose as part of the circumstances surrounding her death. The circumstances of her death have prompted renewed discussion about addiction, mental health, and the responsibilities of companies that work closely with public figures.

Neutrogena has faced particular criticism because Panettiere was associated with the brand for many years. She became a prominent face of the company and served as a global ambassador beginning in the mid-2000s. Her relationship with the skincare company lasted for approximately a decade and made her closely associated with its public image.

Neutrogena Responds to Criticism

Following Panettiere’s death, some fans criticized Neutrogena on social media. Several people called for a boycott of the company, while others posted videos showing themselves throwing away Neutrogena products.

Much of the anger centered on claims Panettiere made about her former relationship with the company. In her 2026 memoir, "This Is Me: A Reckoning," and during a May appearance on the "On Purpose with Jay Shetty" podcast, Panettiere discussed her experience with postpartum depression after the 2014 birth of her daughter, Kaya.

Panettiere said that she believed Neutrogena ended her ambassador relationship after she publicly spoke about her mental health struggles. According to her account, company executives considered her comments inconsistent with the expectations surrounding her role and subsequently ended the partnership.

Neutrogena has not publicly confirmed that Panettiere’s contract was terminated specifically because she spoke about postpartum depression. That distinction remains important when considering the allegations surrounding the former partnership.

The company has nevertheless acknowledged that Panettiere felt unsupported during a particularly difficult period in her life.

In a statement shared on social media, Neutrogena expressed sadness over Panettiere’s death and described her as a valued member of its community for more than a decade. The company also acknowledged that its relationship with her did not reflect the kind of support it wanted to provide.

Neutrogena said it was proud to have worked with Panettiere while also recognizing that she felt abandoned during a challenging time.

A Renewed Conversation About Women’s Health

The controversy has also drawn attention to postpartum depression and the broader issue of women’s mental health.

Postpartum depression can affect women after childbirth and may involve persistent sadness, anxiety, exhaustion, difficulty bonding with a baby, changes in sleep or appetite, and other symptoms. It is a serious health condition and is different from the temporary emotional changes commonly known as the "baby blues."

Panettiere spoke publicly about her own experience, helping bring wider attention to an issue that many women may find difficult to discuss. Her openness has become part of the conversation following her death, particularly because her experiences were discussed publicly during and after her career as a major celebrity.

Neutrogena now says it intends to build on that conversation. The company announced plans to make a significant investment in a community health organization that supports women. According to the company, the initiative is expected to include access to resources for postpartum depression.

The brand said further information would be provided once its plans are finalized.

That announcement represents an attempt by Neutrogena to connect its response to Panettiere’s legacy with tangible support for women facing mental health challenges.

Why the Company Faced Backlash

Some of the criticism directed at Neutrogena focused not only on Panettiere’s previous allegations but also on the company’s initial silence after her death.

The company explained that it chose not to immediately make a public statement because it wanted to respect Panettiere’s family and loved ones during their time of mourning.

For some members of the public, however, the silence was interpreted differently. Social media users questioned why a company that had worked with Panettiere for so many years did not immediately acknowledge her passing.

The situation highlights the complicated relationship between celebrities and corporations. Public figures can become closely associated with brands, but those relationships can change as a person’s career, personal circumstances, or public image evolves.

The controversy also raises questions about how companies respond when their representatives speak openly about sensitive subjects. Mental health, addiction, postpartum depression, and other personal struggles can carry significant stigma. When public figures discuss these experiences, their comments can influence how audiences understand such issues.

At the same time, companies must make their own decisions about partnerships and brand representation. Determining what happened in a particular contractual relationship requires evidence from all sides, rather than relying solely on social media reactions.

Panettiere’s Legacy

Panettiere’s career began at a young age, and she became widely recognized for television roles as well as appearances in films. Her personal struggles later became part of the public conversation surrounding her life.

Her decision to discuss postpartum depression and other difficulties helped bring attention to issues that many people experience privately.

Following her death, those conversations have taken on new significance. Fans, health advocates, and members of the public have continued discussing the importance of seeking help and reducing the stigma surrounding mental health conditions.

Neutrogena’s decision to invest in women’s health initiatives could become one way for the company to respond to the criticism and contribute to a cause connected to Panettiere’s public advocacy.

Whether that effort changes public opinion remains to be seen. For now, the controversy illustrates how corporate relationships can become part of a celebrity’s legacy, especially when questions about mental health and personal hardship are involved.

The focus ultimately extends beyond a skincare brand or a celebrity endorsement. Panettiere’s story has prompted renewed discussion about the need for compassion, access to mental health care, and support for women experiencing postpartum depression.

As Neutrogena develops its planned health initiative, attention will likely remain on whether the company follows through with meaningful action. For Panettiere’s supporters, the most important outcome may be ensuring that conversations about the challenges she experienced continue to encourage greater awareness and support for others.

Source: NTD Television, published Aug. 20, 2026.

Disclaimer: Claims regarding Hayden Panettiere’s death, her relationship with Neutrogena, and the circumstances surrounding her former contract are presented as reported and should not be interpreted as independently verified facts.